UNILIFE CORPORATION (NASDAQ:UNIS) Files An 8-K Submission of Matters to a Vote of Security Holders
Item 5.07.
|
Submission of Matters to a Vote of Security Holders. |
Unilife Corporation (the Company) held its Annual Meeting of
Stockholders (the 2016 Annual Meeting) on December 15, 2016. At
the 2016 Annual Meeting, the following proposals were submitted
by the Companys Board of Directors to a vote of the Companys
stockholders and the final results of the voting on each proposal
are noted below.
Proposal No. 1 The election of the persons named below as
directors to hold office until our annual meeting of stockholders
to be held in 2017 and until his or her successor is duly elected
and qualified or until his or her earlier resignation or removal.
All director nominees were elected and the votes were cast as
follows:
|
Name |
Votes For |
Votes Withheld |
Broker Non-Votes |
|||
|
Jeff Carter |
4,457,772 |
473,779 |
4,259,748 |
|||
|
John C. Ryan |
4,511,381 |
420,170 |
4,259,748 |
|||
|
Harry A. Hamill |
4,540,058 |
391,493 |
4,259,748 |
|||
|
John Lund |
4,374,643 |
556,908 |
4,259,748 |
|||
|
Mary Katherine Wold |
4,434,929 |
496,622 |
4,259,748 |
|||
|
Michael E. Kamarck |
4,593,492 |
338,059 |
4,259,748 |
|||
|
Rosemary A. Crane |
4,566,847 |
364,704 |
4,259,748 |
|||
|
Duane DeSisto |
4,567,016 |
364,535 |
4,259,748 |
|||
Proposal No. 2 Ratification of the appointment of KPMG LLP as our
independent registered public accounting firm for the fiscal year
ending June 30, 2017.
The appointment of KPMG LLP as our independent registered public
accounting firm for the fiscal year ending June 30, 2017 was
ratified and the votes were cast as follows:
|
For |
Against |
Abstain |
Broker Non-Votes |
|
8,857,619 |
203,735 |
129,945 |
– |
Proposal No. 3 Advisory vote regarding the approval of
compensation paid to certain executive officers.
The compensation of the Companys named executive officers was
approved, on an advisory basis, and the votes were cast as
follows:
|
For |
Against |
Abstain |
Broker Non-Votes |
|
3,452,191 |
1,295,733 |
183,627 |
4,259,748 |
Proposal No. 4 Approval of an amendment to the Unilife
Corporation Amended and Restated 2009 Stock Incentive Plan to
increase the number of shares available for issuance under such
Plan by 2,376,837 shares.
An amendment to the Unilife Corporation Amended and Restated 2009
Stock Incentive Plan to increase the number of shares available
for issuance under such Plan by 2,376,837 shares was approved and
the votes were cast as follows:
|
For |
Against |
Abstain |
Broker Non-Votes |
|
3,390,940 |
1,459,522 |
81,089 |
4,259,748 |
About UNILIFE CORPORATION (NASDAQ:UNIS)
Unilife Corporation is engaged in the designing, development and manufacturing of injectable drug delivery systems. The Company has a portfolio of product platforms, including pre-filled syringes, disposable and reusable auto-injectors, drug reconstitution delivery systems, ocular delivery systems, and other systems for the targeted delivery of injectable therapies. The majority of its products are designed for sale directly to pharmaceutical and biotechnology companies supplying them as drug-device combination products, pre-filled and ready for administration by end-users, such as health-care providers or patients. Its other products, such as reusable auto-injectors and certain systems for targeted drug delivery are designed either to be sold to pharmaceutical or biotechnology companies for use as combination products or to be sold directly to a health care provider or end user without having the device pre-filled by a pharmaceutical company. UNILIFE CORPORATION (NASDAQ:UNIS) Recent Trading Information
UNILIFE CORPORATION (NASDAQ:UNIS) closed its last trading session down -0.04 at 2.18 with 76,674 shares trading hands.
